Showing posts with label Stress. Show all posts
Showing posts with label Stress. Show all posts

Tuesday, September 16, 2008

Health Tip: Keep Stress at Bay

(HealthDay News) -- Some stress is unavoidable, but there are things you can do to prevent stress from taking over your life and making health problems worse.

The Cleveland Clinic offers these suggestions:
  • Stick to a healthy diet, get plenty of exercise, avoid smoking and limit the amount of alcohol you drink.
  • Don't allow others to make demands or set expectations for you. Say no, and don't be afraid to stand up for yourself.
  • Take time every day just to relax.
  • Set realistic goals and expectations for yourself, but understand that you can't control everything.
  • Figure out what causes you stress in your life. Eliminate what you can, and learn how to manage other sources of stress.
  • Remind yourself of what you do well and successes that you've had.

Tuesday, April 01, 2008

Will Your New House Make You Sick?

The one we almost bought harbored cancer-causing gas and toxic mold. What buyers must check before their dream home turns into a nightmare
by Amy O'Connor

It was love at first sight. My husband and I couldn’t believe our luck. We met The One so early in our home-hunting process; the house was everything we’d ever dreamed of and more: neat and tidy, wrapped up in a bow.

Or so we thought when we offered asking price and had it accepted. We even bonded with the sweet little-old-lady seller, whose grandmotherly demeanor filled us with confidence about our impending purchase. I envisioned our closing date through a Vaseline-coated lens, complete with baked-from-scratch chocolate chip cookies provided by her and a group hug with both attorneys. Continue reading »

Wednesday, March 05, 2008

Health Tip: When Caregiving Becomes Too Stressful

(HealthDay News) - Caring for a loved one who needs extensive help can be physically and emotionally draining. To continue providing loving care, it's important to monitor your own well-being, too.

Here are some warning signs of caregiver stress, courtesy of the American Academy of Family Physicians:


  • Feeling unusually angry or resentful toward the person you care for, yourself or your family.

  • Withdrawing from social activities.

  • Anxiety.

  • Sleeping too much or having difficulty sleeping.

  • Feeling irritable.

  • Being sick frequently.

more discussion: Forum· Addiction Forum · Ask the Doctors Forum · Ayurveda Forum · Ayurvedic & Thai Herbs Forum · Colon Cleansing Forum · Dental Forum · Diabetes Forum · Diet Forum · General Cleansing Forum · Hepatitis A, B. C Forum · Integrated Medicine Forum · Live Blood Analysis Forum · Ozone-Oxygen-Forum · pH - Alkaline - Acidity Forum · Weight Loss Forum

Tuesday, February 12, 2008

Gene Variations Help Regulate Response to Stress

(HealthDay News) -- Certain variations in a gene that helps regulate stress response offer protection against depression in adults who suffered abuse when they were children, a new study says.

Adults who were abused as children and didn't have the protective variations of the CRHR1 gene had twice the symptoms of moderate to severe depression, compared to those with the variations.

The researchers interviewed more than 400 adults and tested their DNA. About one-third of them had the protective variations in the gene that produces CRHR1, a receptor for the stress hormone corticotropin-releasing hormone (CRH).

Extreme stress in childhood, brought on by factors such as abuse, can hyper-activate the hormone system that regulates stress response, leading to an increased risk of depression in adulthood, the researchers said.

"Our results suggest that genetic differences in CRH-mediated neurotransmission may change the developmental effects that childhood abuse can have on the stress hormone system -- developmental effects that can raise the risk of depression in adults," Dr. Kerry J. Ressler, of Emory University, said in a prepared statement.

"We know that childhood abuse and early life stress are among the strongest contributors to adult depression, and this study brings to light the importance of preventing them," Ressler said. "But when these tragic events do occur, studies like this one ultimately can help us learn how we might be able to better intervene against the pathology that often follows."

The study, funded by the U.S. National Institute of Mental Health (NIMH), is published in the current issue of the journal Archives of General Psychiatry.

NIMH Director Dr. Thomas R. Insel said in a prepared statement: "People's biological variations set the stage for how they respond to different environmental factors, like stress, that can lead to depression. Knowing what those variations are eventually could help clinicians individualize care for their patients by predicting who may be at risk or suggesting more precise avenues for treatment."

More information
Mental Health America has more about depression.

Scientists Reprogram Human Skin Cells Into Embryonic Stem Cells

(HealthDay News) -- U.S. scientists say they've reprogrammed human skin cells into ones with the same blank-slate properties as embryonic stem cells, a breakthrough that could aid in treating many diseases while sidestepping controversy.

Human embryonic stem cells have the ability to become every cell type found in the human body. Being able to create these cells en masse and without using human eggs or embryos could generate a potentially limitless source of immune-compatible cells for tissue engineering and transplantation medicine, said the scientists, from the University of California, Los Angeles.

The researchers genetically altered human skin cells using four regulator genes, according to findings published online in the Feb. 11 edition of the journal Proceedings of the National Academy of the Sciences.

The result produced cells called induced pluripotent stem cells, or iPS cells, that are almost identical to human embryonic stem cells in function and biological structure. The reprogrammed cells also expressed the same genes and could be coaxed into giving rise to the same cell types as human embryonic stem cells, the researchers said.

"Our reprogrammed human skin cells were virtually indistinguishable from human embryonic stem cells," lead author Kathrin Plath, an assistant professor of biological chemistry and a researcher with the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, said in a prepared statement. "Our findings are an important step towards manipulating differentiated human cells to generate an unlimited supply of patient specific pluripotent stem cells. We are very excited about the potential implications."

The UCLA findings confirm similar work first reported in late November by researcher Shinya Yamanaka at Kyoto University and James Thompson at the University of Wisconsin. Together, the studies demonstrate that human iPS cells can be easily created by different laboratories and are likely to mark a milestone in stem cell-based regenerative medicine, Plath said.

Reprogramming adult stem cells into embryonic stem cells has significant implications for disease treatment. A patient's skin cells, for example, could be reprogrammed into embryonic stem cells that could be prodded into becoming beta islet cells to treat diabetes, hematopoetic cells to create a new blood supply for a leukemia patient, or motor neuron cells to treat Parkinson's disease, the researchers said.

These new techniques to develop stem cells could potentially replace a controversial method to reprogram cells called somatic cell nuclear transfer (SCNT), sometimes referred to as therapeutic cloning. To date, therapeutic cloning has not been successful in humans.

"Reprogramming normal human cells into cells with identical properties to those in embryonic stem cells without SCNT may have important therapeutic ramifications and provide us with another valuable method to develop human stem cell lines," study first author William Lowry, an assistant professor of molecular, cell and developmental biology, said in a prepared statement. "It is important to remember that our research does not eliminate the need for embryo-based human embryonic stem cell research, but rather provides another avenue of worthwhile investigation."

However, top stem cell scientists worldwide stress further research comparing reprogrammed cells with stem cells derived from embryos -- considered the gold standard -- is necessary.

More information
The U.S. National Institutes of Health has more about stem cells.

Saturday, February 09, 2008

Depression in Young Doctors Tied to Medication Errors

(HealthDay News) -- Medical residents who are depressed are about six times more likely to make medication errors than those who aren't depressed, says a study that looked a 123 pediatric residents at three children's hospitals in the United States.

Researchers found that 20 percent of the residents were depressed, and 74 percent were burned out. During the study period, the residents made a total of 45 medications errors, and those who were depressed made 6.2 times more medication errors than those who weren't depressed.

There didn't appear to be any link between higher medication error rates and burnout. The study was published online Feb. 7 in the British Medical Journal.

These findings suggest that doctors' mental health may play a more significant role in patient safety than previously suspected, the study authors said. In addition, the high burnout rate among residents in this study -- consistent with other studies -- indicates that methods of training doctors may cause stress that harms residents' health.

The researchers did note that their data was collected before work hour limits were implemented for medical residents in the United States.

More needs to be done to study and improve the mental health and working conditions of doctors, the study authors concluded.

Each year in the United States, as many as 98,000 patients die due to medication errors, and the stress of resident training, including lack of sleep and leisure time, are among the most commonly cited reasons for such errors, according to background information in the study.

While it may seem logical to link medication errors to depression and burnout among doctors, these study findings are not conclusive, researchers from Scotland's University of Aberdeen noted in an accompanying editorial.

Large, prospective trials need to be conducted to pinpoint the factors that cause medication errors, they wrote.

More information
The U.S. Food and Drug Administration has more about medication errors.

Tuesday, December 25, 2007

Realistic Expectations Help Ward Off Holiday Depression

(HealthDay News) -- For many people, heightened expectations, financial and social stress, and memories of lost loved ones can cause tension, anxiety and sadness.

All of that can lead to seasonal blues during the holidays, says an expert at Cedars-Sinai Medical Center.

For example, people who expect difficult relationships to improve just because it's Christmas are likely to be disappointed.

"In terms of relationships, nothing magical 'just happens' during the holidays," Dr. Mark H. Rapaport, chair of the department of psychiatry and behavioral neurosciences at Cedars-Sinai, said in a prepared statement.

"If you don't get along with your in-laws during the year, you're probably not going to get along with them during the holiday season, either. Understanding that before you go to visit them can improve how you'll handle your feelings while you're there," he said.

Planning ahead can help people cope with many sources of holiday-related stress and anxiety.
"If you plan ahead and focus on what you really enjoy about the season, you can spend more time 'living in the moment,' which is the key to getting the most out of each holiday experience," Rapaport said.

He offered some tips for coping with the holidays:
  • Have realistic expectations about interactions with family and friends.
  • Make a list and prioritize activities that you feel are most important.
  • Limit your drinking. Too much alcohol can lead to bad behavior, hangovers, and remorse which, in turn, can lead to depression.
  • Share holiday responsibilities such as shopping, cooking, party planning, and activities.
  • Get regular exercise. Walking for just 30 minutes three times a week can give you a big boost.
  • Keep your holiday spending under control.
  • Eat well, get enough rest, and make time for yourself.
  • Spend time with caring and supportive people and reach out to those who may benefit from your support.
  • Don't worry too much about details. Live in the moment as much as possible and look for meaningful moments throughout the season.

More information
Mental Health America has more about holiday depression and stress.

more discussion: Forum
· Addiction Forum · Ask the Doctors Forum · Ayurveda Forum · Ayurvedic & Thai Herbs Forum · Colon Cleansing Forum · Dental Forum · Diabetes Forum · Diet Forum · General Cleansing Forum · Hepatitis A, B. C Forum · Integrated Medicine Forum · Live Blood Analysis Forum · Ozone-Oxygen-Forum · pH - Alkaline - Acidity Forum · Weight Loss Forum

Friday, November 30, 2007

Health Tip: Female Infertility

(HealthDay News) - About 7.3 million females in the United States aged 15 to 44 had difficulty becoming pregnant or carrying a baby to term in 2002, according to the U.S. Centers for Disease Control and Prevention.




The U.S. Department of Health and Human Services lists these factors that may contribute to female infertility:

  • Age.
  • Stress.
  • Unhealthy diet.
  • Being overweight or obese, or significantly underweight.
  • Strenuous exercise.
  • Smoking or drinking alcohol.
  • Sexually transmitted disease.
  • Health conditions that affect hormone production.

more discussion: Forum
· Addiction Forum · Ask the Doctors Forum · Ayurveda Forum · Ayurvedic & Thai Herbs Forum · Colon Cleansing Forum · Dental Forum · Diabetes Forum · Diet Forum · General Cleansing Forum · Hepatitis A, B. C Forum · Integrated Medicine Forum · Live Blood Analysis Forum · Ozone-Oxygen-Forum · pH - Alkaline - Acidity Forum · Weight Loss Forum




Oxy-Powder® Complete Cleansing System

Oxy-Powder® Complete Cleansing System

$147.75
[ learn more ]

Add to Cart

Complete Cleansing System with Livatrex™, Oxy-Powder®, Latero-Flora™, and two bottles of ParaTrex®.

Tuesday, August 28, 2007

Food for the Aging Mind

Agricultural Research
08-27-07
Originally Published:20070801.

Scientists know that certain nutrients and other key chemical compounds are essential to human brain function. Serious deficiencies in some of these, such as vitamin B12 and iron, can lead to impaired cognitive function due to neurological, or nerve fiber, complications.

Cognition can be defined as the ability to use simple-to-complex information to meet the challenges of daily living.

So, could careful attention to diet help protect the aging brain from problems with nerve cell signals involved in memory and cognition? A clear-cut answer could greatly affect the 77 million baby boomers who are now facing retirement. Their independence, quality of life, and even economic status will largely be defined by their ability to traffic information signals as they age.

In researching the nutrition-brain connection, new technologies are being used, such as those that take images of the brain or actually count individual brain cells. Behavioral tests that measure motor and cognitive skills-or lack thereof-are also providing insights. Yet the science of nutrition and brain function is relatively new and evolving.

Agricultural Research Service scientists at several locations nationwide are contributing to a growing body of research that explores the effect of diet and nutrition on the brain and its function across the lifespan.

Weight Loss Plan Kit

Weight Loss Plan Kit

$172.80
[ learn more ]

Add to Cart

Includes: Oxy-Powder, Slimirex (180 Count), Weight Loss Secrets Revealed, Ten Super Secrets for Weight Loss




Boosting Neuronal Function
The brain's billions of neurons "talk" to one another through chemical neurotransmitters that convey signals through neural pathways. These chemical transporters- which include norepinephrine, serotonin, and dopamine-are key to signal movement.

Although people naturally lose brain cells throughout their lives, the process of neuronal death does not necessarily accelerate with aging. "There is a lot of individual difference," says ARS neuroscientist James Joseph. "Loss of mental agility may be less due to loss of brain cells than to the cells' failure to communicate effectively."

Joseph heads the Neuroscience Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University in Boston. There, researchers are looking at the beneficial effects of certain dietary plant compounds to learn how they affect brain function.

"Vitamins and minerals in plant foods provide protective antioxidants," says Joseph. "But fruits, vegetables, nuts, seeds, and grains contain thousands of other types of compounds that contribute significantly to the overall dietary intake of antioxidants.

"A partial measure of the antioxidant effect is called 'ORAC,' for Oxygen Radical Absorbance Capacity. ORAC scores are now showing up in charts and on some food and beverage packages. They may be helpful in choosing foods to include in your diet."

Perhaps there is no better place in which to gauge the power of antioxidants than between the minute connections of the nerve cells.

Bucking Long-Held Dogma
Eight years ago, Joseph and colleagues began publishing a series of studies, done in rodents, that shed light on the relationship between various diets and the mechanisms behind cognitive losses in specific neighborhoods of the aging brain.

Many in the series are groundbreaking in that they challenge the long-accepted belief that the central nervous system, which includes the brain, is not capable of regenerating itself. Other published studies in the series echo similar findings based on primate and human brain research at the Salk Institute for Biological Studies, San Diego, California. Scientists there, using new technologies, disputed the notion that the brain does not make new neurons-a process called "neurogenesis"-into old age: It does, but at a much slower rate.

One of the first of Joseph's studies, published in the Journal of Neuroscience, showed a protective effect of consuming antioxidants. Study rats were fed-from adulthood to middle age-vitamin E, strawberry extracts, or spinach extracts, all with similar ORAC values. Animals receiving the high-antioxidant diets did not experience the age-related cognitive performance losses seen in control rats fed standard chow.

A later study, also published in the Journal of Neuroscience, showed a reversal of functional loss among rats on special diets. Each of three groups of rats, equivalent in age to 63-year-old humans, was fed a different high-antioxidant extract. A control group was fed standard chow.

After 8 weeks-equivalent to about 10 years in humans-the rats' performance levels were measured.

The rats fed the spinach, strawberry, or blueberry extracts effectively reversed age-related deficits in neuronal and cognitive function. In addition, the blueberryfed group far outperformed their peers while traversing a rotating rod to test balance and coordination.

"Despite their status as 'senior citizens,' those rats showed remarkable stamina on neuromotor function tests," says psychologist and coauthor Barbara Shukitt-Hale, also with the Neuroscience Laboratory.

Examination of the brain tissue of those blueberry-fed rats showed much higher levels of dopamine than were found in the other groups. Dopamine has many functions within the brain. In particular, it can affect the way the brain controls movements.

"We suspected that the combined antioxidant potency of compounds in blueberry extract may have reduced inflammatory compounds in the brains of these older animals," says Joseph.

"Inflammation ordinarily contributes to neuronal and behavioral shortfalls during aging."
Tests have since shown that blueberry compounds cross the blood-brain barrier and localize in rodent brain tissue.

Hard News: Brain Plaques
Later, the lab's researchers published an Alzheimer's disease model study in Nutritional Neuroscience. They studied mice that carried a genetic mutation for promoting increased amounts of amyloid beta, a protein fragment found within the telltale neuritic plaque, or "hardening of the brain," seen in Alzheimer's disease.

Although the exact cause of Alzheimer's is not completely understood, experts have recently identified one mechanism involving the insufficient breakdown and recycling of amyloid protein in the brain. That mechanism is both genetic and physiological. In those individuals, normally harmless amyloid protein turns into fragments of amyloid beta, which build up as plaque in the brain rather than being escorted into cellular recycling. That action leads to cell death and weakened neuronal communication.

In the mouse study, beginning at age 4 months-early adulthood-half the brainplaqued group was fed a diet that included blueberry extract for 8 months. The other half was fed standard rat chow and so was a control group of mice that didn't carry the amyloid-plaque mutation.

At 12 months-early middle age-all groups were tested for their performance in a maze.

The brain-plaqued mice that were fed the blueberry extract performed as well as the healthy control mice and performed much better than their brain-plaqued peers fed standard chow.

A look at the plaqued brains of both the blueberry-fed and chow-fed mice after death revealed no difference in the number of brain plaques in either group. "Amyloid-beta-induced plaques are only one aspect of Alzheimer's disease," says Joseph. "But the fact that we saw a dietinduced behavioral difference, despite a similarity in plaque density in both these animal groups, is significant."

The team found increased activity of a family of enzymes called "kinases" in the brains of the amyloid-plaqued mice that were fed blueberry extract. Two kinases found in particular, ERK and PKC, are important in mediating cognitive function, such as converting short-term memory to long-term.

"These kinase molecules are involved in signaling pathways for learning and memory," says Joseph. "It could be that the increased kinase activity within the plaque-ridden brains of the blueberry-fed mice enhanced the signaling in certain receptors."

Brain Cells Are Born
Another HNRCA rat study looked at the aged brain's ability to change physiologically- a condition scientists refer to as "neuronal plasticity." In addition to cell division and differentiation, or "mission assignment," brain tissue undergoes many other changes throughout aging.

For example, a newborn sprouts billions of nerve cells while soaking up information from the environment. But lower levels of synapse growth continue in waves throughout the lifespan.

Littleused synapses are eliminated, while others are strengthened in a neuronal pruning process, of sorts.

Repair mechanisms involve neural immune cells, called "microglia," that seek to heal and protect injured brain tissue; enzymes that regulate safe chemical levels; and genes that are expressed in response to inflammation.

The neuronal-plasticity study investigated the physiological link between nutrition and the memory-control hippocampal area of the aged brain. That region, in the center of the brain, is essential for what's called "working" or "short-term" memory. It receives and processes data, and then, if needed, passes it on for storage.

Neurogenesis also plays a role in the formation of new memories. The capacity of the hippocampus to produce new neurons is thought to be greatly diminished during aging. But this study suggested that old rats fed blueberry extracts for a short time had increased neurogenesis in the dentate gyrus area of their brain's hippocampus. The dentate gyrus is one of the few regions of the brain where neurogenesis occurs.

"We found changes in the proliferation of neurons in blueberry-fed rats," said Gemma Casadesus, formerly a graduate student with the Neuroscience Laboratory and now with Case Western Reserve University. In maze tests, blueberry-fed aged lab rats showed improvement in cognition over chow-fed peers. "There was an association between the proliferation of neuronal precursor cells and better performance of spatial memory," she says.

The researchers don't yet know whether the cognitive improvements seen in the aged blueberry-fed rats translate to humans. "But it's an important step in learning about the brain's ability to rescue itself from age-associated declines in physiological function," Casadesus says.

Can You Hear Me Now?
Neurons that can't get their messages through signaling pathways are like cell phones that can't get their signals through to other cell phones. Why does this happen?

As the brain matures, cell division becomes largely restricted to specific regions of the brain, and brain cells tend to become more vulnerable to two partners in crime: oxidative stress and inflammation.

In the body, free radicals-weakened atoms formed during activities of daily living-are missing an electron and want to bond with neighboring biomolecules to stabilize. The problem is that unless neutralized, free radicals cause cellular damage known as "oxidative stress."

Cellular antioxidant defense systems counterbalance these rogue molecules, but they're not 100 percent effective-particularly as the body and brain mature. And the brain is thought to be especially vulnerable to oxidative stress.

"Weighing just 3 pounds, the brain accounts for only 2 percent of the body's total mass, yet it uses up to half of the body's total oxygen consumed during mental activity," says Joseph.

"Phytochemicals, together with essential nutrients in foods, provide a health-benefits cocktail of sorts. It is feasible that continued research in this area will point to dietary regimens that are effective in boosting neuronal function."

Inflammation is thought to be stoked by the overactivation of microglia-the neural immune cells mentioned earlier.

Microglia are usually dormant, but they migrate to the site of any brain injury. These sentries make up about 20 percent of the cell population in certain regions of the brain.

While seeking to protect and repair tissue, microglia cells produce and send out molecular stress signals, some by way of defensive cytokines, as a bugle call to other cells. Those signals begin a cascade of reactions, including the activation of genes that express proteins and other stress chemicals to help clear away cellular debris.

Microglial activation by amyloid beta is thought to be a key event in the progression of Alzheimer's disease. "When microglia are stuck in an always-on loop in response to plaque buildup in the brain, they become problematic in and of themselves," says Joseph.

This year, Francis Lau, a molecular biologist in the Neuroscience Laboratory, published a study that investigated whether blueberry extracts could have a preventive effect on inflammatory signals coming from activated microglia cells.

Microglial activation is considered the hallmark of inflammation in the central nervous system. For this study, Lau used a rodent microglial cell line that has previously served as a model to study plaqueinduced microglial activation.

Lau exposed groups of those test cells to various levels of blueberry extracts. He then challenged the cells with oxidative stress by exposing them to a toxin-lipopolysaccharide- that triggers secretion of inflammatory chemicals.

Neuroinflammation has been linked to the expression of genes that spew two inflammatory enzymes, iNOS and COX-2, and two cytokines, IL-1b and TNF-a.

Lau used real-time PCR (polymerase chain reaction) to find and measure expression of genes that produce iNOS and COX-2 in the stress-induced cell cultures. He found that the blueberry treatment significantly reduced that expression.

The blueberry extract also markedly lessened secretion of the two inflammatory cytokines. In fact, says Lau, "In cells exposed to the highest blueberry extract concentration, the amount of TNF-a cytokine found was next to nothing- essentially identical to that found in the control cells."

Looking to the Future
The food industry is now using a range of new and existing product ingredients to gain entrance into the emerging brainhealth market. Some are producing food labels that list ORAC values-for example, for use on containers of polyphenol-rich fruit juices and teas. So far, however, there has been no review conducted by the U.S. Food and Drug Administration on health benefits from eating berries.

Future studies at HNRCA will ideally include use of new diagnostic tools as well as human clinical trials. Neuroimaging equipment, for example, could be used to monitor the influence of various dietary factors on development of plaque within the human brain. Such studies aim to find the best dietary regimens to help adults preserve their mental capabilities while aging.-By Rosalie Marion Bliss, ARS.

This research is part of Human Nutrition, an ARS national program (#107) described on the World Wide Web at www. nps.ars.usda.gov.

James A. Joseph is with the USDA-ARS Human Nutrition Research Center on Aging at Tufts University, 711 Washington St., Boston, MA 02111; phone (617) 556-3178, fax (617) 556-3222, e-mail jim.joseph@ ars.usda.gov.

Friday, July 27, 2007

Health Tip: Causes of Fainting

(HealthDay News) -- Fainting occurs due to a sudden drop in blood flow to the brain, resulting in brief loss of consciousness. Fainting can be accompanied by dizziness or nausea.

Here are some common triggers, courtesy of the U.S. National Library of Medicine:
  • Straining during urination or a bowel movement.
  • Excessive coughing.
  • Standing for too long in the same position, or quickly standing up from a lying position.
  • Severe pain, stress, fear or emotional distress.
  • Excessive bleeding or dehydration.
  • Medications used to treat conditions like high blood pressure, anxiety, allergies and nasal congestion.
  • Use of drugs or alcohol.
  • Low blood sugar.

Sunday, July 15, 2007

No Clear Evidence Meditation Can Boost Health: Study

(HealthDay News) -- There's no definitive evidence that meditation eases health problems, according to an exhaustive review of the accumulated data by Canadian researchers.

"There is an enormous amount of interest in using meditation as a form of therapy to cope with a variety of modern-day health problems, especially hypertension, stress and chronic pain, but the majority of evidence that seems to support this notion is anecdotal, or it comes from poor quality studies," concluded researchers Maria Ospina and Kenneth Bond of the University of Alberta/Capital Health Evidence-based Practice Centre, in Edmonton.

They analyzed 813 studies focused on the impact of meditation on various conditions, including high blood pressure, cardiovascular disease and substance abuse.

Released Monday, the report looked at studies on five types of meditation practices: mantra meditation; mindfulness meditation; yoga, Tai Chi and Qi Gong.

Some of the studies suggested that certain types of meditation could help reduce blood pressure and stress and that yoga and other practices increased verbal creativity and reduced heart rate, blood pressure and cholesterol in healthy people.

However, the report authors said it isn't possible to draw any firm conclusions about the effects of meditation on health, because the existing studies are characterized by poor methodologies and other problems.

"Future research on meditation practices must be more rigorous in the design and execution of studies and in the analysis and reporting of results," Ospina said in a prepared statement.

Bond added that the new report doesn't prove that meditation has no therapeutic value, but it can inform medical practitioners that the "evidence is inconclusive regarding its effectiveness."

For the general public, the report "highlights that choosing to practice a particular meditation technique continues to rely solely on individual experiences and personal preferences, until more conclusive scientific evidence is produced," Ospina said.

The study was funded by the U.S. National Center for Complementary and Alternative Medicine in Bethesda, Md., part of the National Institutes of Health.

More information
The U.S. National Center for Complementary and Alternative Medicine has more about meditation for health purposes.

Monday, May 14, 2007

Simple Workout Urged for Pregnant Women on Bed Rest

(HealthDay News) -- Pregnant women restricted to bed rest can and should do safe, specially-designed physical activity, say experts at the American Physical Therapy Association (APTA).
Each year in the United States, an estimated 700,000 women with high-risk pregnancies (including nearly all those carrying triplets or more) are put on bed rest, the APTA said. But, in many cases, the incapacitating effects of total bed rest are not being addressed, leaving some expectant mothers ill-prepared for pre- and post-partum physical and psychological challenges.

"As a result of prolonged bed rest, pregnant women experience an array of symptoms ranging from cardiovascular deconditioning, musculoskeletal discomforts, stressful postures and positions, skin breakdown, muscle weakness, as well as psychological issues such as guilt, stress, and depression," Jean Irion, a professor of physical therapy at the University of South Alabama in Mobile, said in a prepared statement.

Irion teaches physical therapists across the United States to develop safe physical activity programs for pregnant women on bed rest.

"Physical therapy is often equated with exercise, and many physicians equate exercise to a strong potential for exacerbating a given high-risk condition, so they don't suggest pregnant women restricted to bed rest see a physical therapist. This is a huge mistake," according to Irion.

She said physical therapists work to minimize loss of muscle tone and strength and to make the women as comfortable as possible.

"We're not training these women to compete in a triathlon following delivery. Our aim is for these women to maintain some strength, flexibility and range of motion in the upper and lower extremities, so they'll be prepared for the demands of lifting carrying, and holding their babies," Irion said.

More information
The Nemours Foundation has more about bed rest during pregnancy.

Monday, May 07, 2007

New Study Stresses Mammogram's Importance in Breast Cancer Decline

(HealthDay News) -- The decline in U.S. breast cancer cases is caused not only by fewer women using hormone replacement therapy but also by the use of mammography screening, new research suggests.

"Two distinct patterns are observed in breast cancer trends," wrote Dr. Ahmedin Jemal, strategic director for cancer surveillance for the American Cancer Society, in a report published in the May 3 online edition of the journal Breast Cancer Research.

After colleagues presented an abstract at a breast cancer symposium that attributed the 7 percent decline in U.S. breast cancer cases in the years 2002 to 2003 to the reduced use of hormone replacement therapy, Jemal's team decided to look at an older data base.

The researchers who linked the decline to reduced hormone use looked at a large data base from 2002 and 2003 called SEER (Surveillance, Epidemiology, and End Results). In 2002, a large federally funded trial -- part of the Women's Health Initiative -- was halted when evidence emerged of an increased risk of heart disease and breast cancer due to hormone therapy.

After that, women in large numbers went off their hormone replacement regimens.

But Jemal's team looked at older SEER data bases, from 1975 to 2003. The researchers looked at breast cancer incidence rates by tumor size, tumor stage, and whether the tumor was estrogen-receptor positive or negative among women who were age 40 or older in the years studied.

They found that the decline in breast cancer cases also dropped prior to the 2002-2003 SEER data, although the decrease was less dramatic -- about 5 percent between 1999 and 2000 there was a 5 percent drop, according to Jemal.

"The point is breast cancer started to decrease before 2002," Jemal said. And screening mammograms were the reason, he added.

The decline in breast cancer rates directly attributed to mammography, he said, has now leveled off.

"The message for women over 40 is still, they should get a mammogram every year so the tumor [if there is one] can be detected," Jemal said.

The new study is "a more nuanced analysis," said Roshan Bastani, professor and associate dean for research at the University of California, Los Angeles, and associate director for cancer prevention and control at the university's Jonsson Comprehensive Cancer Center. "It shows there were declines in breast cancer that started before the recent declines."

While from a public health perspective a plateau may have been reached when it comes to the benefits of screening mammography, Bastani added, it's still crucial for women over age 40 to keep their mammogram appointments. "About 75 percent of [U.S.] women are getting screened. That has not changed since 1999," she said.

More information
To learn more about breast cancer, visit the American Cancer Society.

Friday, March 30, 2007

Physical Activity Cuts Risk of Repetitive Strain Injury

(HealthDay News) -- Being physically active may reduce the risk of repetitive strain injuries at work, according to a new Canadian study.

Researchers at the University of British Columbia in Vancouver analyzed data from the 2003 Canadian Community Health Survey. They found that the overall prevalence of repetitive strain injury (RSI) was about 10.9 percent, and that the prevalence of work-related RSI was about 4.7 percent. Upper body injuries (most commonly wrist/hand, shoulder and elbow) accounted for 63 percent of RSI in full-time workers.

Physical work demands, work-related stress, obesity, and smoking were among the risk factors associated with upper-body work-related RSI, the study said. Women and people ages 30-49 were also at higher risk. Being physically active appeared to help reduce the risk of work-related RSI.

"This finding provides evidence for a hypothesis that an active lifestyle outside of work may protect against work-related RSI, adding another potential health benefit to leisure-time physical activity participation," the study authors wrote.

Physical activity may promote mechanical and metabolic processes in the musculoskeletal system that counter the repetitive or sedentary effects of many jobs, the researchers said. It may also improve upper body muscle strength and better balance of movement.

"Work-related RSI is a common problem that has significant costs in terms of lost wages and productivity, medical care and quality of life," the study authors wrote. "It is important to identify lifestyle factors that may protect against RSI in order to inform employers, compensation boards, and the working population. Identification of safe physical activities may reduce RSI and provide multiple other health benefits."

The findings are published in the April issue of the journal Arthritis Care & Research.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about repetitive motion disorders.

Sunday, March 18, 2007

Diabetes Epidemic Spreading Worldwide: Experts

(HealthDay News) -- More than two-thirds of the world's estimated 246 million diabetics come from less-affluent developing nations, and more must be done to curb a disease that now rivals HIV/AIDS in terms of suffering and death around the globe.

That sobering assessment was offered by experts gathered at this week's Global Changing Diabetes Leadership Forum in New York City, which included keynote speaker former President Bill Clinton. The conference is one of the largest such gatherings ever of scientists, health-care advocates and government leaders focused on the issue.

"This truly is an epidemic," warned Dr. Martin Silink, president of the International Diabetes Federation (IDF), which represents more than 200 diabetes associations across 158 countries. "Seventy percent of the global burden of diabetes is now in developing countries, even though that seems paradoxical. People think that it should be in the developed world where there is access to fast food and lots of obesity."

But rapid lifestyle changes are affecting the health of people in China, India, South America, and elsewhere, he said. "As their economies develop, diabetes is now subverting the gains of economic development," Silink said.

The issue has gained such urgency that the United Nations' General Assembly in December passed a global resolution to encourage the prevention, treatment and care of diabetes. The U.N. has only passed one such disease-targeted resolution before, when it vowed to fight HIV/AIDS.

Some statistics from the IDF:
By 2025, the number of people with diabetes is expected to rise to 380 million worldwide, with 80 percent living in the developing world.

Each year, another 7 million people develop diabetes, while 3.8 million die of diabetes-linked causes.

In many countries in Asia, the Middle East and the Caribbean, diabetes already affects 15 percent to 20 percent of the adult population.

India now has the largest number of diabetics (almost 41 million) in the world, followed by China (nearly 40 million), the United States (19.2 million) and Russia (9.6 million).

Diabetes increasingly affects the young or middle-aged, with more than half of diabetics in developing countries between the ages of 40 and 59.

According to the experts, a "perfect storm" of genetics and social change is driving the spread of obesity-linked type 2 diabetes in poorer countries. Visitors to today's China quickly notice McDonald's, KFC and other fast-food outlets springing up in major cities. At the same time, the foot and bicycle are making way for the car on urban streets.

Scientists have also long understood that Asians, Hispanics and blacks are more vulnerable, genetically, to develop type 2 disease compared with those of European descent.

"They simply don't have to get as obese as a European to get diabetes," Silink explained. Among non-Europeans, even a relatively modest increase in abdominal fat -- the so-called "spare tire" -- can trigger changes that lead to insulin insensitivity and diabetes.

"The risk of diabetes in a European starts rising after a body mass index (BMI, a ratio of weight to height) of about 25 or 26," the normal threshold for overweight, Silink said. "But for a person coming from Bangladesh or India, that risk curve starts after a BMI of just 22," he said.

A person who is 5-feet, 8-inches tall and weighs 145 pounds has a BMI of 22.

Too often, expensive, pay-as-you-go health-care systems in developing countries mean diabetes isn't even detected until it reaches crisis levels, Silink added. The results -- prolonged disability, amputation, even death -- can destroy a family's income.

Urban stress is another factor driving the epidemic, as the world's poor seek employment in cities, Silink said. For reasons that remain unclear, "we know that simply moving from a rural environment to a city doubles your risk of diabetes without any change in body mass," he said. "And if you have to go to a 'mega-city' -- a population of over 10 million -- the risk probably rises fourfold."

Another expert said it's not too late to put the brakes on this developing crisis, however.
Dr. Alan Moses was the former chief medical officer of Harvard's Joslin Diabetes Center and is now associate vice president of medical affairs at pharmaceutical giant Novo Nordisk, which sponsored the conference.

"We tend to think of the costs associated with diabetes and worry that putting appropriate resources into diabetes is going to cost more," he said. "But diabetes is one of the few conditions where when you improve health, you actually reduce the cost burden on society. It should be viewed as an investment with a real return."

Certain steps taken by governments in the developed world are already helping. For example, Sen. Guy Barnett of Australia, himself a type 1 diabetic, said his government is moving to change what he labeled an "obesinogenic" environment Down Under.

Along with the United States, "we are one of the fattest countries on Earth," Barnett told reporters at a press conference held Wednesday. "But for governments everywhere, (diabetes) is a monster that is getting bigger and bigger."

With one in 10 Australian children now obese, the Australian government has mandated healthy school lunches, boosted funding for after-school physical activity programs and negotiated with fast-food giant McDonald's to make menus healthier. Former U.S. President Clinton helped broker similar deals with food companies last year to keep unhealthy sodas and snacks out of American schools.

Those and other initiatives can and should be tested in countries worldwide, Silink said. In one sense, he said, developing countries have a real edge on the West, since "they are still in the process of developing their new towns, their urban centers.

"So, in terms of town planning, societal engineering, they have a chance to engineer it for health and not for conditions that are detrimental to human health," Silink said. "It's up to the diabetes world to work with the various organizations to make this happen."

More information
Find out more about diabetes at the American Diabetes Association.

Monday, January 29, 2007

Researching Alternatives: A Talk With Donald Abrams

By Bob Huff
June 2003
You have a reputation as being a rigorous clinical researcher and tough advocate for making evidence-based treatment decisions.

Yet you've also been very open to studying a number of alternative and complementary therapies that have been used in the HIV patient community. How did all these concerns come together and what are you involved with these days?

I was training in oncology at UC San Francisco just as the first AIDS cases were reported. I helped found the AIDS program there and I've been participating in academic clinical research for over 20 years. More recently I've become an associate fellow of the Program in Integrative Medicine at the University of Arizona that was founded by Andrew Weil.

This is a two-year program, mostly online, that is increasing my training and background in integrative medicine, including things like botanical medicine, manual medicine, and spirituality. It's been a stimulating experience so far and I'm really enjoying it.

I've been interested in complementary medicine since the very beginning of my career, so one of the reasons I'm doing the fellowship is to learn more that I can integrate into my own healthcare discussions with my patients. Of course another impetus is to see what other things we might want to do clinical research on.

My intention is to continue to investigate the complementary and alternative approaches that our patients are using. We want to determine whether or not they may be beneficial, but also determine whether or not they may be harmful, particularly in how they interact with the conventional medications that patients are taking.

In the earliest days of AIDS we didn't have any treatment for this new disease; people were dying and everybody was frightened. Being here in San Francisco, we were near the Linus Pauling Research Institute in Palo Alto, so there were a number of people in the city who were proponents of high doses of Vitamin C.

One of the first responses we saw in the early '80s were storefront clinics opening up where people went to receive intravenous injections of very high doses of Vitamin C.

At that point in time we didn't even know that it was a virus causing the disease. So I used to go around on the lecture circuit with someone who would talk to audiences of concerned people who listened to him while hooked up to intravenous infusions of Vitamin C.

Then I would speak as the academician who cautioned people that we really don't know if this is beneficial and there may be some dangers to being hooked up to intravenous vitamin C, and so on. Ultimately, this led to me to write a grant proposal in collaboration with the Linus Pauling Institute.

It was right about the time we learned that HIV was the cause of AIDS so we wrote a proposal to the NIH to study the in vitro effects of Vitamin C on HIV. That grant didn't get funded.

In San Francisco at that time there were also a number of DNCB proponents. DNCB, dinitroclorobenzene, is actually a photographic chemical used for developing pictures, but it is also a skin sensitizer that had been used to test for delayed hypersensitivity reactions.

There were people who believed that somehow it might be useful in restoring some of the T-cell immunity that patients with this new disease were lacking. So there were people who would paint themselves weekly or so with DNCB until they developed these skin reactions, thinking that the skin reaction was some sort of improved T-cell immune response that would help combat the virus.

And again, seeing that people were using this and seeing that we really didn't have much else happening, I worked with some of the DNCB proponents, as well as some experts from the University of California -- I remember Jay Levy was involved, as was Marcus Conant and others -- and we wrote a protocol that we submitted to the FDA for funding. That also was rejected.

Around the time that AZT first became available in 1986, I went to a conference in Japan where I was introduced to some investigators from the Ueno Fine Chemicals company who told me that they had the cure for this disease. They said it was something that was very commonly used in Japan but they couldn't tell me about it until I signed a confidentiality agreement.

That turned out to be dextran sulfate. Not long after I was going through the process of filing the paperwork to get approval from the FDA to do a phase I study of dextran sulfate in the United States when evidently some people heard about it.

They realized that it was a product that was widely available in Japan -- I believe it was used for lowering cholesterol -- so they started an importation scheme similar to what had happened in earlier days with isoprinosine and ribavirin, which were brought across the Mexican border.

But people had now become more sophisticated in their methods and began to import dextran sulfate from Japan to sell in the underground AIDS therapy market.

I remember that activists stormed the offices of a Japanese drug distributor in New York for refusing to make dextran sulfate more widely available. Ultimately it became such a political issue that, even though my clinical trial here in San Francisco didn't show much benefit, Congress got involved and the AIDS Clinical Trial Group (ACTG) was asked to do a study of dextran sulfate through the NIH-funded mechanism. It turned out the drug was not even absorbed into the blood.

Another Japanese product I worked with was lentinin, which was an intravenously administered extract of shiitake mushroom. In Japan it was felt to be an immune booster for patients with cancer. Although it was being used by mainstream doctors in Japan, it was an alternative therapy here because it was not something that we had ever learned about or used in hospitals in the U.S. That's David Eisenberg's description of what an alternative therapy is -- that it's not taught about in medical schools or widely available in U.S. hospitals -- and certainly shiitake mushroom extracts qualified. Again, that's another study we did that had negative findings;

there was no benefit to the intravenous infusions of lentinin. Since I've learned more about botanicals, it would seem to me that if there were immune enhancing benefits to shiitake mushrooms then they are more likely to be obtained by eating them rather than by injecting an extract intravenously.

During that time I was also involved with studies of conventional therapies. Even in the days of early AZT monotherapy, which I was not a big supporter of, I was involved in trying to put some evidence behind the claims of the proponents for these various agents. And since that time, I've had a constant history of investigating conventional therapies through the federally-funded CPCRA (Community Programs for Clinical Research on AIDS), and more recently through the ESPRIT study of interleukin 2, as well as in other, sometimes pharmaceutical industry-sponsored trials. But always ongoing with those studies, I've been involved with clinical trials of complementary and alternative interventions.

When we first became aware of immune thrombocytopenic purpora (ITP) in AIDS, I worked with a nurse who was very interested in therapeutic touch and we studied men with low platelet counts to see if therapeutic touch could decrease their stress and increase their platelet counts. That was another study that turned out to be fairly negative.

I then became interested in traditional Chinese medicine (TCM) and, in fact, one of the colleges of TCM here in San Francisco sent me to China in 1989 just to learn about Qigong (Chi Kung) -- that exercise that's felt to improve the immune system -- to see if it was something that I wanted to study here. Although I never studied Qigong I collaborated with Misha Cohen from the Quan Yin Healing Arts Center here in San Francisco. We did three studies of traditional Chinese herbal interventions for, first, symptomatic HIV, then for patients with diarrhea without a pathogenic source, and then another study for patients with anemia.

The last two were hindered by the fact of being initiated about the time that HAART became available, so patients with diarrhea as well as anemia became scarce. There were also a lot of pills that needed to be taken in these Chinese herbal investigations and patients at that time were taking huge amounts of pills with their antiretroviral regimens, so the studies weren't very attractive. None of these studies had spectacular results and the anemia study was terminated for poor enrollment.

Have "soft endpoints" such as life satisfaction created a problem for designing and conducting credible studies?

The TCM herbal study that we published in 1996 investigated herbs versus placebo in symptomatic HIV infection. At the time of the study in 1993, we had patients with about 14 symptoms on average and we found that there was a significant decrease of symptoms in the herb-treated group -- they decreased from 14 to 12 -- whereas the other group still had 14 symptoms. We also found that they had improved "life satisfaction" which improved by a factor of +0.86 or thereabouts.

Yet, if you look at the rest of the results, the Chinese herbal patients actually lost weight over 12 weeks compared to the placebo group, and their CD4 counts also dropped -- not statistically significant, but it was a trend. So that was an example of where their symptoms improved and their life satisfaction increased, but the parameters that we would normally look at to see if a patient is doing well (i.e., weight and CD4 count) went in the wrong direction. So, although I was also first author on a study that showed that epoetin alfa improves quality of life in HIV patients who are anemic, I'd have to say that a study whose main endpoint is quality of life is something I would find difficult to interpret.

The CPCRA actually did a large study of acupuncture for patients with HIV-related peripheral neuropathy that was published in JAMA. That was a landmark, having the NIH support an acupuncture study, although, again, it turned out to have negative results; acupuncture didn't appear to be effective in treating peripheral neuropathy.

About this time I began trying to study another botanical, which has consumed my efforts for the past decade, and that would be cannabis, or marijuana. Starting in 1992 I began proposing and developing clinical trials to investigate first the effectiveness -- but then I realized that that wasn't going to happen -- so subsequently, the safety of smoked marijuana in patients with HIV.

We finally completed a study in the year 2000, that we hope will soon be published, that looked at the safety of marijuana in patients taking protease inhibitor regimens. And since that time we have obtained funding from the State of California that allows us now to conduct clinical trials to look at the potential effectiveness of smoked marijuana in patients with various syndromes. We have also just completed a pilot study in patients with HIV peripheral neuropathy, which allowed us to ascertain that there was some effectiveness of marijuana. But an open-label pilot study is not going to prove that, so we're now in the process of continuing on with a randomized, placebo controlled, double-blind trial in patients with HIV-related peripheral neuropathy. We're also doing marijuana studies in patients with cancer who have pain who are on opioid analgesics, and another study to look at the effect of smoked marijuana in patients who have delayed nausea and vomiting from breast cancer chemotherapy.

It was working with marijuana and all the problems that are inherent in studying a plant as a therapy that has led me to a broader interest in botanicals and the use of substances that come from nature as medicinal agents. Certainly, for thousands of years, people have depended primarily on these things. Whether or not they worked is unclear, but as an oncologist I know that many of my most potent chemotherapeutic agents were derived from plants. So right now we are waiting to hear if a protocol we submitted to the National Center for Complementary and Alternative Medicine (NCCAM) to investigate the lipid lowering effects of oyster mushrooms in patients on Kaletra is being funded. There's good evidence that mushrooms, including oyster mushrooms in particular, have some activity for lowering blood lipids and cholesterol.

We're also just finishing a three-year NCCAM grant studying the effects of DHEA, dehydroepiandrosterone, which is an over-the-counter adrenal steroid that people are taking for many reasons. We received a grant to investigate it as an antiviral and to see what impact it has on the immune system. Hopefully that data will be available by the end of the year and we will know if DHEA had any impact, positively or negatively, in our patients.

The goal, ultimately, would be to submit a center grant to the NCCAM, to allow us to establish a center here for the study of botanicals in HIV because there are still a number of herbal preparations and mushroom extracts that warrant further investigation for their potential benefit -- and to make sure that they're not harmful in our patients.

Safety keeps coming up again and again as one of the inarguable justifications for doing this research.

There's not a huge amount that we know about some of these botanical products and how they're metabolized, but there's probably more than people think. There are a number of textbooks available that talk about herb-drug interactions. That was the question in our marijuana study: is there an interaction between cannabinoids and protease inhibitors, which are both metabolized by cytochrome P450 enzymes in the liver, that may alter the activity of the protease inhibitors such that patients lose their viral suppression when they mix cannabis with their treatments?

And in fact, in our article that was already published in AIDS, we saw no such effect. We've all heard about garlic and St. John's Wort and their interactions, and I think there are many other agents that we would like to study to make sure that they are not having significant interactions with protease inhibitors. We don't want people to either lose control of their viremia (through underdosing) or experience toxicity (through overdosing) because of antiretroviral concentrations that have been affected by herb-drug interactions.

You had to be enormously persistent to accomplish your marijuana study. In the current political climate, is it going to be more difficult to do marijuana studies?

I think we're blessed to live in the State of California, which is somewhat of a freestanding republic in and of itself. In 1996, the people of California voted to allow physicians to talk to their patients about the medicinal use of cannabis. Then, through the work of Senator John Vasconcellos, one of our state senators, appropriations were made to the University of California that established the Center for Medicinal Cannabis Research (http://www.cmcr.ucsd.edu/). And that Center has had funds for the past three years that allows it to support clinical trials to investigate the use of marijuana for medicinal purposes.

Whereas the NIH and NIDA, via their congressional mandate, could only give marijuana to clinical trials that show that it was harmful (they are the National Institute on Drug Abuse, not for Drug Abuse, as NIDA's director Alan Leshner always reminded me), they were not really able to provide us with marijuana to study the benefits. But now, they have modified their system so they can provide marijuana for peer reviewed clinical trials that will look at its effectiveness as a therapeutic agent -- as long as they are not funding it. So they have now created this ability for us to obtain government marijuana.

Is there a need to increase provider knowledge about these issues?

I think a part of the problem is a lack of communication from both sides. Patients don't really perceive that these substances are something that they need to tell their doctor about -- in fact many studies show they don't want to tell their doctor because they're afraid they're going to be reprimanded or told that they're wasting their money. And many physicians never even think about asking about these things as potential confounders or as things that are causing clinical symptoms.

There also may be a variable of where in the country you are. I know many surveys show that we in the West have the highest percentage of people in the population who are using complementary and alternative interventions. So many of my colleagues here might be more familiar with how to ask the question and what to be looking for.

I remember once seeing a patient at our drop-in clinic who clearly had a drug rash. I looked through his chart -- this was when we had paper charts -- and he had a high CD4 count and a low viral load but he wasn't taking any medications.

So I said to the guy, "You're not taking any medications, huh?" And he said, "No."
"Are you taking any vitamins?" And he said, "Yeah."

So I asked him what he took and he listed about four or five vitamin preparations. Then I asked, "Do you take any herbs?" And he said, "Sure."

And so I listed the three or four herbal substances th
at he took.
"Do you take any minerals?" And he said, "Yeah."
By the time I finished I had a list of 12 different things he was taking.
So I asked, "Well, how come everybody else wrote down that you don't take anything?" And he said, "Well, nobody ever asked me before."


more info at:
http://www.dreddyclinic.com/integrated_med/integrated_med.htm

Friday, November 17, 2006

Breast Cancer Diagnosis Brings Serious Distress

(HealthDay News) -- Nearly half of women newly diagnosed with breast cancer undergo clinically significant emotional distress or symptoms of psychiatric disorders such as depression and Post-traumatic stress disorder (PTSD), new research shows.

In many cases, the women's psychological troubles aren't noted by doctors or aren't adequately treated, the study authors added.

The study included 236 women newly diagnosed with breast cancer who had not yet started cancer treatment.

Forty-seven percent underwent significant distress following their diagnosis, the U.S. team found. The most common problem was moderate to severe emotional distress (41 percent). The most commonly cited sources for that distress were the cancer diagnosis (100 percent), uncertainty about treatment (96 percent), and worries about physical problems (81 percent).
The researchers also found that 21 percent of the women met criteria for psychiatric disorders, including major depression (11 percent) and PTSD (10 percent). These disorders were linked to major declines in the women's daily functioning.

Many of the women with depression were already taking antidepressants but continued to have significant depression symptoms. This suggests that even when they're identified as being depressed, newly-diagnosed breast cancer patients may be undertreated, the study authors said.

"This study has at least two important implications," researcher Mark T. Hegel, of the department of psychiatry and the Norris Cotton Cancer Center at Dartmouth Medical School in New Hampshire, said in a prepared statement.

"First, we need to do a better job of getting the word out about how well we can treat breast cancer," he said. "These emotional disorders are almost certainly due in part to the fear and helplessness that continues to result from receiving a cancer diagnosis.

Second, we need to assess for and provide adequate intervention for the women meeting criteria for these severe but very treatable psychiatric conditions."

More information
Breastcancer.org offers advice on dealing with breast cancer fears.

Thursday, November 09, 2006

The Effects of SRT on Four Bottled Waters

Over the years I have had the honor of working with Clarus Transphase Scientific, the developers of the Q-Link Pendant and other related products in researching the effects of their patented Sympathetic Resonance Technology on organic and inorganic matter.

We have had several papers published in the Journal of Alternative and Complementary Medicine specific to SRT.

I have found the technology of SRT to be effective in increasing the zeta potential or life force of matter. The following is a blinded pilot study I conducted on four commercially bottled waters and the chemical and electrical changes that took place in that water, treated with SRT.

The results are impressive and demonstrate the efficacy of the SRT technology.

Summary: The effects of SRT or Sympathetic Resonance Technology on water were measured. The pH, ORP and rH2 of water, with and without SRT processing were measured for four (4) different types of water.

All four (4) waters were commercially bottled waters. The results showed some consistent changes due to SRT including improved pH, ORP and rH2 in all waters tested.

In brief, it is shown that SRT increases pH, lowers ORP and rH2, which could help to reduce states of oxidative stress or over-acidity of the blood and tissues of living organisms.

Introduction: This is an exploratory pilot study to test a variety of drinking waters with and without SRT-treatment. The purpose is to compare the waters without SRT treatment to waters with SRT treatment to measure any changes in the hydrogen ion concentrations (pH) and the proton/electron concentrations (ORP and rH2), to demonstrate how SRT processing of the water affects positively the pH, ORP and rH2.

Materials and Methods: Four (4) types and eight (8) samples of commercially available bottled drinking waters were processed with SRT for 45 hours. These eight (8) samples from four (4) types of waters were then compared with the same four (4) types of waters without SRT using a Thermo-Orion multi-function pH/ORP meter.

The eight (8) samples of bottled water treated with SRT and the four (4) samples of bottled water not treated with SRT were tested twice for pH, ORP and rH2. Average values were calculated from duplicate measurements. Prior to testing all samples there was no prior knowledge of what samples were treated with SRT and what samples were not treated with SRT, making this a blinded exploratory pilot study.

Table 1 summarizes the results of 72 measurements.

Explanations of pH, ORP and rH2: The pH is a scientific exponential measurement of the concentration of hydrogen ions (H+) and hydroxyl ions (OH-) in an aqueous solution ranging from 1 to 14 with 7 being neutral. A pH below 7 would be acidic; having a higher concentration of hydrogen ions (H+) and a lesser amount of hydroxyl ions (OH-) and a pH, above 7 would be alkaline, having a lesser concentration of hydrogen ions (H+) and higher concentrations of hydroxyl ions (OH-).

The pH scale is exponential, so a pH of 6 would have 10 times more hydrogen ions (H+) and 10 times less hydroxyl ions(OH-) than a pH of 7 and a pH of 8 would have 10 times less hydrogen ions (H+) and 10 times more hydroxyl ions (OH-).

There are two ways to measure the electron/proton activity, or the energy potential of an aqueous solution: ORP and rH2. The value of ORP (oxidative reduction potential) quantifies the amount of energy in the aqueous solution by numbering its electrons.

It is expressed in milli volts (mV), either positive or negative. Typically water samples show a positive ORP or proton saturation of over +100 mV. A positive ORP means that the aqueous solution is acidic or oxidized and has no potential energy for further oxidation: that is, it has no free electrons for energy. Such an aqueous solution has no antioxidant or anti-acid potential to support life.

A negative ORP means that the aqueous solution possesses electrical potential - energy, and is rich in electrons to support living organisms. Aqueous solutions with a negative ORP has antioxidant or anti-acid properties and are beneficial in that they can buffer or neutralize acids and thus reduce oxidative stress.

Water with a negative ORP is the only water that can support life, buffer gastrointestinal and metabolic acids and provide electrons to support the energy needs of any living organism. Water with a negative ORP no longer exists on the earth because of inorganic and organic contamination of our oceans, rivers and streams.

All negative ORP water has to be created chemically, electrically or through the use of SRT or a combination thereof. Consider rH2 (reduction of hydrogen; sometimes called "redox") as sort of a backup measurement to ORP. rH2, is measured on a scale, just the way pH is.

The rH2 scale ranges from 0 to 44, with 22 being neutral; the lower the number, the greater the concentration of electrons. With each step, the number of electrons increases by a factor of 10; water with rH2 of 22 has 10 times more electrons than water at 23.

An increase of just two places on the scale, then, means 100 times fewer electrons. Ideally, you want your water to have an rH2 of 22 or less. Unfortunately, most municipalities have, on the average, an rH2 of 30 or greater.

That's 100 million fewer electrons.Conclusions: The waters not treated with SRT showed positive ORP's at +378 to +431 and rH2's at 27.9 to 28.04. The untreated Evian water was the best bottled water with an alkaline pH of 7.39, an ORP of +390 and an rH2 at 27.9, but was still lacking in electrical potential and electron concentration. All other non treated waters were acidic, with AquaFina, a purified municipal water, being the most acidic, at a pH of 5.83.

However, the effects of SRT on pH, ORP and rH2 were similar for all four (4) waters and all eight (8) samples, in that SRT increased pH from .44% to 19.21%, reduced ORP from 48.21% to 60.09% and reduced rH2 6.64% to 9.15% respectively. (Refer to Table 1)

Of the four (4) types of waters and eight (8) samples treated with SRT, AquaFina had the best result with a pH prior to treatment of 5.83 and with SRT treatment, a pH increase to 6.95, a 19.21% increase.

The ORP went from +431 to +200 and a rH2 of 28.31 to 25.93, indicating a 1500 times increase of electrons or electrical potential.This pilot study showed the effects of SRT on physical properties as well as the subtle energetic properties of water.

However, not all waters appear to react in the same way to SRT. Some waters showed a stronger effect than others. The most notable changes were the increases of the pH, and reductions in ORP and rH2 of the AquaFina water, which is nothing more than treated tap water.

This means that water treated with SRT can reduce hydrogen ions, increase hydroxyl ions, decrease protons and increases electrons and thus lower oxidative stress, gastrointestinal and metabolic acids and provide energy for living organisms to sustain life.

Moreover, this is consistent with previously published research on SRT, which shows that SRT makes human cells, tissues, organs and living organisms more resistant and resilient to the ravages of acidic stress.

The fact that various types of waters react somewhat differently to SRT may be due to their molecular structure and mineral composition and the ability of the atoms of the waters ability to hold new information.

It is also possible that the various bottled waters may already contain information from the processing at the bottling plant, which makes it harder for them to hold SRT processing.

In summary: SRT or Sympathetic Resonance Technology is shown to enhance drinking water properties including its electrical or energetic potential and antioxidant/anti-acid capacities.

Water Non SRT Water Type pH % Change1) Evian Mineral 7.30 pH2) Calistoga Mineral 6.81 pH3) Dasani Treated Tap 6.60 pH4) AquaFina Treated Tap 5.83 pHWater With SRT 1) Evian Sample 1 Mineral 7.54 pH 2.03%2) Evian Sample 2 Mineral 7.65 pH 3.52%3) Calistoga S-1 Mineral 6.84 pH .

44%4) Calistoga S-2 Mineral 6.91 pH 1.47%5) Dasani S-1 Treated Tap 6.81 pH 3.18%6) Dasani S-2 Treated Tap 6.81 pH 3.18%7) AquaFina S-1 Treated Tap 6.95 pH 19.21%8) AquaFina S-2 Treated Tap 6.68 pH 14.58%Water Non SRT Water Type ORP% Change rH2 %

Change1) Evian Mineral +430 mV 27.902) Calistoga Mineral +404 mV 28.04

3) Dasani Treated Tap +378 mV 27.78

4) AquaFina Treated Tap +431 mV 28.31Water With SRT

1) Evian Sample 1 Mineral +202 mV 48.46% 26.03 6.77%
2) Evian Sample 2 Mineral +202 mV 48.21% 26.02 6.74%
3) Calistoga S-1 Mineral +190 mV 52.97% 25.90 7.63%
4) Calistoga S-2 Mineral +200 mV 50.50% 26.00 7.27%
5) Dasani S-1 Treated Tap +156 mV 57.73% 25.56 7.99%
6) Dasani S-2 Treated Tap +156 mV 57.73% 25.56 7.99%
7) AquaFina S-1 Treated Tap +172 mV 60.09% 26.01 6.77%
8) AquaFina S-2 Treated Tap +193 mV 55.22% 26.02 6.74%

Table 1: pH, ORP and rH2 values on four (4) types of water with and without SRTFor more information concerning SRT and the Q-Link Pendants and other related energy products, visit our website at:
www.phmiracleliving.com
ph Miracle Center

Saturday, November 04, 2006

Chronic Fatigue Syndrome Campaign Launched

(HealthDay News) -- U.S. health officials on Friday launched a major campaign to increase awareness of chronic fatigue syndrome, an illness that has labored under an intense level of controversy.

"This disease has been shrouded in a lot of mystery. Sometimes people question if it's real or not real," Dr. Julie Gerberding, director of the U.S. Centers for Disease Control and Prevention, said at a news conference. "We hope to help patients know they have an illness that requires medical attention and help physicians be able to diagnose the illness, and be able to validate and understand the incredible suffering that many people and their families experience in this context."

The campaign will consist of public service announcements, brochures, a "tool kit" for health-care professionals and a photo exhibit called "The Faces of Chronic Fatigue Syndrome," which will travel to cities across the country throughout 2007.

"We hope this will be a turning point in the public's awareness of the disease as well as in health-care professionals' ability to diagnose and treat it," Kim McCleary, president and CEO of the CFIDS Association of America, said at the news conference.

"This launch is so important to increasing understanding of this illness," added Dr. Nancy Klimas, of the University of Miami Miller School of Medicine. "Historically, lack of credibility of this illness has been a major stumbling block."

According to Dr. William Reeves, of the CDC's National Center for Infectious Diseases, the level of impairment experienced by people with chronic fatigue syndrome is comparable to that of multiple sclerosis, AIDS, end-stage renal failure and chronic obstructive pulmonary disease.

One CFS patient, Adrianne Ryan, said that sometimes taking a walk or a shower was too much, and resulted in her collapsing for weeks afterwards. Ryan is a former marathoner.

Doctors still don't know what causes CFS or how to treat it successfully, but more than 4,000 studies over the past two decades show definite underlying biological abnormalities, said Dr. Anthony Komaroff, of Harvard Medical School.

"This is not an illness that people can imagine they have. It's not a psychological illness," he said. "That debate, which has raged for 20 years, should now be over."

Among other things, Komaroff pointed out, the brain hormone systems of people with CFS are different than those without the disease. Brain functioning is also impaired and cells' energy metabolism seems to be compromised.

Analyses of the activity levels of 20,000 genes in people with CFS have found abnormalities in genes related to the part of brain activity mediating the stress response, Reeves said.
Some 1 million Americans suffer from the disease. Women are affected at about four times the rate as men and non-white women are affected more than white women. The disease can affect any age and demographic but is most likely to strike when a person is 40 to 59 years of age.

According to a large study conducted in Wichita, Kans., only half of people with CFS have consulted a physician and only 16 percent have been diagnosed and treated, although studies have shown that those who get appropriate care early in the illness have better long-term results. A quarter of people with the disease were unemployed or receiving disability, with the average affected family foregoing $20,000 annually in income. That amounts to $9.1 billion in lost income and wages for the U.S. economy as a whole, the study found.

While there's reason to be happy with advances in the basic scientific knowledge of the disease, Klimas said she was less happy with advances in care. Over the past 20 years, she said, she has treated more than 2,000 people with CFS who were "angry and defiant, frustrated, trying to convince physicians, friends and families that this was a real illness."

"We need much more work to understand the biological underpinnings and translate this into clinical practice," she said. "At the same time, there are effective strategies we can use right now, treatments that do help and help significantly."

More information
Visit the U.S. Centers for Disease Control and Prevention for more on chronic fatigue syndrome.

Gene May Help Spur Breast Cancer's Spread

(HealthDay News) -- Multiple copies of a gene called uPAR are associated with the spread of early-stage breast cancer, U.S. researchers report.

The gene offers a promising target for drugs to slow or halt the progression of the disease, says a team from the University of Texas Southwestern Medical Center at Dallas. It could also serve as a screening tool for determining which kinds of drugs a breast cancer patient will respond to, the researchers said.

The study was published in this week's issue of the Proceedings of the National Academy of Sciences.

The researchers analyzed individual tumor cells from 72 patients with advanced breast cancer. They found that about 20 percent to 25 percent of breast cancer patients carry too many copies of the uPAR gene, which starts a process that allows cancer cells to escape into the bloodstream and to adjacent tissues.

"The uPAR system probably plays a role in metastases in many of the common solid tumors," study senior author Dr. Jonathan Uhr, a professor in the Cancer Immunobiology Center, said in a prepared statement.

He and his colleagues also found that uPAR may amplify the effects of the breast cancer-causing gene HER-2.

"This gene, uPAR, is an important oncogene, and that is why we determined whether or not it is amplified. Unexpectedly, it is usually amplified in the same tumor cell with HER-2 gene amplification. This has significant implications for treatment with targeting agents," Uhr said. "Moreover, we stress the value of individual tumor cell analysis for providing information that cannot be obtained by conventional pathological examination."

More information
The U.S. National Cancer Institute has more about breast cancer.

ClickComments

Dr. Group's Secret to Health Kit

Dr. Group's Secret to Health Kit

$39.94
[ learn more ]

Add to Cart

Dr. Group's Secret to Health Kit offers simple at-home solutions for cleansing internally and externally thereby reducing toxins, restoring the body's natural healing process, and helping you achieve true health and happiness.